ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $388,322 | -20.4% | 29,940 | +7.2% | 0.00% | – |
Q1 2024 | $487,658 | +85.5% | 27,930 | 0.0% | 0.00% | – |
Q4 2023 | $262,821 | -23.3% | 27,930 | -8.9% | 0.00% | – |
Q3 2023 | $342,584 | -27.9% | 30,670 | +38.1% | 0.00% | – |
Q2 2023 | $475,294 | -39.9% | 22,210 | +13.7% | 0.00% | – |
Q1 2023 | $790,198 | -24.2% | 19,540 | -12.8% | 0.00% | – |
Q4 2022 | $1,042,746 | -60.6% | 22,415 | -56.1% | 0.00% | -100.0% |
Q3 2022 | $2,647,000 | -55.6% | 51,029 | -59.6% | 0.00% | -66.7% |
Q2 2022 | $5,966,000 | -24.3% | 126,204 | +14.0% | 0.00% | 0.0% |
Q1 2022 | $7,882,000 | +76.1% | 110,729 | +85.0% | 0.00% | +50.0% |
Q4 2021 | $4,476,000 | +238.8% | 59,854 | +157.4% | 0.00% | +100.0% |
Q3 2021 | $1,321,000 | +17.0% | 23,250 | -9.4% | 0.00% | – |
Q2 2021 | $1,129,000 | -10.8% | 25,650 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $1,265,000 | +17.6% | 25,650 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $1,076,000 | -8.1% | 25,570 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,171,000 | -20.0% | 25,570 | -12.3% | 0.00% | 0.0% |
Q2 2020 | $1,463,000 | -2.4% | 29,140 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,499,000 | -16.7% | 29,140 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $1,800,000 | -41.6% | 29,140 | -43.2% | 0.00% | -50.0% |
Q3 2019 | $3,082,000 | -32.7% | 51,300 | -5.5% | 0.00% | -33.3% |
Q2 2019 | $4,582,000 | +5.2% | 54,300 | +19.1% | 0.00% | 0.0% |
Q1 2019 | $4,356,000 | +34.9% | 45,600 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $3,230,000 | -13.8% | 45,600 | +4.0% | 0.00% | 0.0% |
Q3 2018 | $3,746,000 | -21.8% | 43,830 | +6.0% | 0.00% | -33.3% |
Q2 2018 | $4,790,000 | +68.1% | 41,330 | +17.3% | 0.00% | +50.0% |
Q1 2018 | $2,850,000 | -41.0% | 35,230 | -57.2% | 0.00% | -33.3% |
Q4 2017 | $4,827,000 | +12.0% | 82,260 | -10.7% | 0.00% | 0.0% |
Q3 2017 | $4,311,000 | +71.6% | 92,120 | +31.9% | 0.00% | +50.0% |
Q2 2017 | $2,512,000 | +7.4% | 69,820 | -8.0% | 0.00% | 0.0% |
Q1 2017 | $2,338,000 | -47.2% | 75,910 | -42.5% | 0.00% | -50.0% |
Q4 2016 | $4,424,000 | +21.7% | 132,060 | -3.3% | 0.00% | +33.3% |
Q3 2016 | $3,636,000 | +151.5% | 136,630 | +108.4% | 0.00% | +200.0% |
Q2 2016 | $1,446,000 | +71.3% | 65,560 | +128.0% | 0.00% | 0.0% |
Q1 2016 | $844,000 | +6.3% | 28,750 | +19.6% | 0.00% | 0.0% |
Q4 2015 | $794,000 | -6.7% | 24,040 | +2.1% | 0.00% | 0.0% |
Q3 2015 | $851,000 | -19.9% | 23,540 | -0.3% | 0.00% | 0.0% |
Q2 2015 | $1,062,000 | +142.5% | 23,600 | +65.0% | 0.00% | – |
Q1 2015 | $438,000 | -16.4% | 14,300 | +38.8% | 0.00% | – |
Q4 2014 | $524,000 | +28.4% | 10,300 | 0.0% | 0.00% | – |
Q3 2014 | $408,000 | +21.4% | 10,300 | +32.1% | 0.00% | – |
Q2 2014 | $336,000 | +11100.0% | 7,800 | +10163.2% | 0.00% | – |
Q1 2014 | $3,000 | +50.0% | 76 | 0.0% | 0.00% | – |
Q4 2013 | $2,000 | -84.6% | 76 | -86.8% | 0.00% | – |
Q3 2013 | $13,000 | -45.8% | 576 | -57.4% | 0.00% | – |
Q2 2013 | $24,000 | – | 1,352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
RA Capital Management | 250,000 | $9,893,000 | 1.17% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |